Log in

IMAC Stock Price, News & Analysis (NASDAQ:IMAC)

$2.95
-0.32 (-9.79 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$2.95
Now: $2.95
$3.34
50-Day Range
$2.92
MA: $3.59
$4.06
52-Week Range
$2.60
Now: $2.95
$7.20
Volume4,200 shs
Average Volume24,922 shs
Market Capitalization$24.80 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
IMAC Holdings, Inc. operates a chain of integrated medicine and chiropractic regeneration centers. The company's outpatient clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. As of September 17, 2018, it had 11 clinics, including 6 owned and 5 managed clinics in Kentucky, Missouri, and Tennessee, the United States. The company was founded in 2000 and is based in Brentwood, Tennessee.

Industry, Sector and Symbol

Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IMAC
CUSIPN/A
CIKN/A
Phone844-266-4622

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$6.70 million

Profitability

Miscellaneous

EmployeesN/A
Market Cap$24.80 million
Next Earnings Date11/15/2019 (Estimated)
OptionableNot Optionable

Receive IMAC News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.


IMAC (NASDAQ:IMAC) Frequently Asked Questions

What is IMAC's stock symbol?

IMAC trades on the NASDAQ under the ticker symbol "IMAC."

How were IMAC's earnings last quarter?

IMAC Holdings Inc (NASDAQ:IMAC) released its quarterly earnings results on Friday, August, 16th. The company reported ($0.21) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.02 by $0.23. The business had revenue of $3.76 million for the quarter, compared to analysts' expectations of $3.97 million. View IMAC's Earnings History.

When is IMAC's next earnings date?

IMAC is scheduled to release their next quarterly earnings announcement on Friday, November 15th 2019. View Earnings Estimates for IMAC.

Has IMAC been receiving favorable news coverage?

News headlines about IMAC stock have been trending somewhat negative on Saturday, according to InfoTrie. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. IMAC earned a daily sentiment score of -1.5 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for IMAC.

Are investors shorting IMAC?

IMAC saw a increase in short interest in the month of September. As of September 30th, there was short interest totalling 9,700 shares, an increase of 288.0% from the August 30th total of 2,500 shares. Based on an average daily volume of 13,900 shares, the short-interest ratio is presently 0.7 days. Approximately 0.3% of the shares of the stock are short sold. View IMAC's Current Options Chain.

Who are some of IMAC's key competitors?

Some companies that are related to IMAC include Acadia Healthcare (ACHC), BioTelemetry (BEAT), Hanger (HNGR), AAC (AAC) and Biocorrx (BICX).

Who are IMAC's key executives?

IMAC's management team includes the folowing people:
  • Mr. Jeffrey S. Ervin M.B.A., CEO & Director (Age 41)
  • Mr. D. Anthony Bond CPA, Chief Financial Officer (Age 57)
  • Dr. Matthew C. Wallis, COO & Director (Age 45)
  • Mr. Jeff Ervin, Chief Exec. Officer
  • Dr. Ian A. White Ph.D., Chief Scientific Officer (Age 44)

When did IMAC IPO?

(IMAC) raised $4 million in an IPO on the week of February 11th 2019. The company issued 900,000 shares at $5.00 per share. Dawson James Securities and Cuttone acted as the underwriters for the IPO.

How do I buy shares of IMAC?

Shares of IMAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is IMAC's stock price today?

One share of IMAC stock can currently be purchased for approximately $2.95.

How big of a company is IMAC?

IMAC has a market capitalization of $24.80 million and generates $6.70 million in revenue each year. View Additional Information About IMAC.

What is IMAC's official website?

The official website for IMAC is http://www.imacregeneration.com/.

How can I contact IMAC?

IMAC's mailing address is 1605 WESTGATE CIRCLE, BRENTWOOD TN, 37027. The company can be reached via phone at 844-266-4622 or via email at [email protected]


MarketBeat Community Rating for IMAC (NASDAQ IMAC)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  51 (Vote Outperform)
Underperform Votes:  67 (Vote Underperform)
Total Votes:  118
MarketBeat's community ratings are surveys of what our community members think about IMAC and other stocks. Vote "Outperform" if you believe IMAC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMAC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Featured Article: What are gap-down stocks?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel